Literature DB >> 12594975

Complementary and alternative groups contemplate the need for effectiveness, safety and cost-effectiveness research.

M J Kelner1, H Boon, B Wellman, S Welsh.   

Abstract

OBJECTIVE: To examine the views of complementary and alternative medicine (CAM) groups on the need to demonstrate the effectiveness, safety and cost-effectiveness of their therapies and practices.
DESIGN: Qualitative interviews were conducted with 22 representatives of three CAM groups (chiropractic, homeopathy and Reiki). Qualitative content analysis was used to identify similarities and differences among and across groups.
SETTING: Ontario, Canada.
RESULTS: There were striking differences in the views of the three sets of respondents. The chiropractors agreed that it was essential for their group to provide scientific evidence that their interventions work, are safe and cost-effective. The leaders of the homeopathic group were divided on these points and the Reiki respondents showed virtually no interest in undertaking such research.
CONCLUSIONS: CAM groups that are more formally organized are most likely to recognize the importance of scientific research on their practices and therapies.

Mesh:

Year:  2002        PMID: 12594975     DOI: 10.1016/s0965-2299(02)00076-6

Source DB:  PubMed          Journal:  Complement Ther Med        ISSN: 0965-2299            Impact factor:   2.446


  3 in total

1.  Classification of complementary and alternative medical practices: Family physicians' ratings of effectiveness.

Authors:  Christopher J Fries
Journal:  Can Fam Physician       Date:  2008-11       Impact factor: 3.275

Review 2.  Economic evaluations of homeopathy: a review.

Authors:  Petter Viksveen; Zofia Dymitr; Steven Simoens
Journal:  Eur J Health Econ       Date:  2013-02-10

Review 3.  Is complementary and alternative medicine (CAM) cost-effective? A systematic review.

Authors:  Patricia M Herman; Benjamin M Craig; Opher Caspi
Journal:  BMC Complement Altern Med       Date:  2005-06-02       Impact factor: 3.659

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.